I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now
Looking for a dividend stock you can sleep well owning? Here's why Johnson & Johnson could be the long-term healthcare anchor your portfolio needs.
Investors searching for a reliable dividend stock to invest in often find themselves drawn to Johnson & Johnson (NYSE: JNJ). While its yield may not be the most attractive, the company's consistent track record and strong business make it the best dividend stock to purchase, in my opinion.
For the past 64 years, Johnson & Johnson has raised its dividend annually, a remarkable streak that spans various economic conditions, including recessions, interest rate cycles, patent expiration periods, and corporate restructuring challenges. This consistency has earned it the title of Dividend King. In April 2026, the company's board increased the quarterly per-share dividend from $1.30 to $1.34, marking a 3.1% rise. This decision was reaffirmed in July for the third quarter.
As of now, the annual dividend stands at approximately $5.36 per share, offering a yield of around 2% at current prices. This yield may seem modest, but when combined with the company's share repurchase program, the total shareholder yield appears more promising. The combination of reliable dividends and share buybacks is designed to generate steady, long-term growth without surprising investors. This approach emphasizes quiet, consistent compounding, rather than seeking sudden, dramatic returns.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.